Ethel Clemente
Pediatric Endocrinology · Modesto, CANPI 1497986731
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 126 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 14.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,012, more than ten times the $26 reported in 2019.
Across 126 payments — averaging $21.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$388
- Regeneron Healthcare Solutions, Inc.$274
- Novo Nordisk$258
- Ascendis Pharma Endocrinology Inc$246
- AbbVie$230
- Tolmar, Inc.$192
- plus $1K from 22 others
What the payments were for
- Food & beverage$2,67798%
- Education$472%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 16 | $388 |
| Regeneron Healthcare Solutions, Inc. | 14 | $274 |
| Novo Nordisk | 10 | $258 |
| Ascendis Pharma Endocrinology Inc | 10 | $246 |
| AbbVie | 12 | $230 |
| Tolmar, Inc. | 8 | $192 |
| Azurity Pharmaceuticals, Inc. | 10 | $170 |
| Kyowa Kirin, Inc. | 6 | $130 |
| Sanofi-aventis U.S. LLC | 5 | $124 |
| Xeris Pharmaceuticals, Inc. | 4 | $78 |
| Acadia Pharmaceuticals Inc | 3 | $73 |
| Soleno Therapeutics, Inc. | 2 | $54 |
| QOL Medical, LLC | 2 | $52 |
| AstraZeneca | 3 | $48 |
| Tandem Diabetes Care, Inc. | 2 | $40 |
| Nestle Healthcare Nutrition Inc. | 2 | $40 |
| Pfizer | 2 | $39 |
| Ultragenyx Pharmaceutical Inc. | 2 | $39 |
| Aquestive Therapeutics, Inc. | 2 | $38 |
| Arbor Pharmaceuticals, Inc. | 2 | $36 |
| Aucta Pharmaceuticals, Inc. | 2 | $34 |
| Baxter Healthcare | 1 | $26 |
| Sanofi | 1 | $22 |
| Rhythm Pharmaceuticals, Inc. | 1 | $21 |
| Neurelis, Inc. | 1 | $21 |
| Mirum Pharmaceuticals, Inc. | 1 | $20 |
| Ironwood Pharmaceuticals, Inc | 1 | $19 |
| Cranial Technologies, Inc | 1 | $14 |
How this compares
$2,724 in reported general payments places this provider in the 65th percentile of 168 pediatric endocrinology providers in California.
Other pediatric endocrinology in Modesto
- Gnanagurdasan PrakasamSacramento$805K
- Swati ElchuriVentura$210K
- Karen KleinSan Diego$195K
- Francine KaufmanLos Angeles$184K
- Lynda PolgreenOrange$167K
- Kevin KaisermanWest Covina$150K
- Amrit BhangooLong Beach$140K
- Mitchell GeffnerLos Angeles$129K
- Stephen GitelmanSan Francisco$105K
- David MaahsStanford$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.